Filters: Author is Anderson, G. F. [Clear All Filters]
Variation in the Ratio of Physician Charges to Medicare Payments by Specialty and Region. Jama. 2017;317:315-318.
.
Physician Charges and Medicare Payments. Jama. 2017;317:1803.
.
Pharmaceutical Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing. Ann Intern Med. 2018;168:436-437.
.
Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry. Appl Health Econ Health Policy. 2018;16:753-763. Abstract
.
Multiple chronic conditions and life expectancy: a life table analysis. Med Care. 2014;52:688-94. Abstract
.
Market Power: Price Variation Among Commercial Insurers For Hospital Services. Health Aff (Millwood). 2018;37:1615-1622. Abstract
.
Limited distribution networks stifle competition in the generic and biosimilar drug industries. Am J Manag Care. 2018;24:e122-e127. Abstract
.
Increasing frequency and share of dermatologic procedures billed by nonphysician clinicians from 2012 to 2016. J Am Acad Dermatol. 2018;79:1159-1161.
.
High-Need, High-Cost Patients: Who Are They and How Do They Use Health Care? A Population-Based Comparison of Demographics, Health Care Use, and Expenditures. Issue brief (Commonwealth Fund). 2016;26:1-14. Abstract
.
Higher Hospital Spending on Occupational Therapy Is Associated With Lower Readmission Rates. Med Care Res Rev. 2017;74:668-686. Abstract
.
Health System Performance for the High-Need Patient: A Look at Access to Care and Patient Care Experiences. Issue brief (Commonwealth Fund). 2016;27:1-12. Abstract
.
Do hospitals provide lower-quality care to minorities than to whites?. Health affairs (Project Hope). 2008;27:518-527. Abstract
.
Commentary on Gross and Laugesen. Journal of Health Politics, Policy and Law. 2018;43:793-795.
.
Attributes common to programs that successfully treat high-need, high-cost individuals. Am J Manag Care. 2015;21:e597-600. Abstract
.
Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer. N Engl J Med. 2018;378:1857-1859.
.
Access to Antihypertensive Drugs in China. Circulation. 2018;138:1777-1779.
.